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Cerebrospinal fluid lysozyme in the diagnosis of
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N. Selvakumar, G.S. Acharyulu & R. Prabhakar
Tuberculous meningitis (TBM) is a
serious form of extra-pulmonary tuber-
 culosis associated with high mortality and
morbidity in children and adults. The diag-
nosis based on clinical and
bioche
gical confirmatiun is not
Hence, there is a need
with high degree of specificity and sensiti-
vity to aid in the diagnosis of tuberculous
meningitis in its early stages.
Serum lysozyme has been found to be
elevated in, conditions characterised by
epitheloid cell granulomas, especially
sacroidosis1, tuberculosis2 and leprosy3.
In the present study, an attempt has been
to elucidate the role of cerebro
fluid (CSF) lysozyme levels in the
diagnosis of TBM by comparing the en-
zyme levels in patients clinically diagno-
sed as tuberculous meningitis (with and
without bacteriological evidence) with
those in patients of non-tuberculous
me ingitis (non-TBM) and control sub-
jects with non-inflammatory condition
of the nervous system.
The lysoplate assay method as des-
cribed by Osserman and Lawlor4 as fol-
lowed to estimate the lysozyme levels.
The zone of lysis was found to be linearly
related to the log concentration of lyso-
zyme standard. Batch variation (lysoplates
prepared in different batches) and day-
today variation were studied and the
overall coefficient of variation of the
estimate with 16 observations was less
than 5 per cent.
The diagnosis of TBM was based on
clinical criteria and biochemica1 charac-
teristics and cellular profile of CSF. The
480 CSF lysozyme in TB meningitis 
patients in the control group had no
clinical evidence of meningitis and were
admitted to the hospital for investigation
of non-inflammatory conditions of the
central nervous system. The CSF samples
were obtained before the start of treat-
ment from children below 15 yr of age
with IBM and non-TBM. All the speci-
mens were subjected to bacteriological
examination for evidence of tuberculosis.
A total of 66 CSF samples (37 TBM,
16 non-TBM, 13 controls) were studied.
All the CSF samples were stored at –20°C
till they were assayed. The CSF samples
and standards were coded and randomly
allocated to the lysoplate wells.
Results & Discussion 
The TBM patients were divided into
culture-positiveand culture-negative
group based on CSF culture positivity
for Mycobacierium tuberculosis The re-
sults of lysozyme estimation in TBM
and non-TBM patients and controls are
shown in the Fig. Lysozyme could be
detected in all the 11 patients of TBM
with CSF cultures positive for M. tuber-
culosis. Of the 11, 9 showed lysozyme
levels >2.7 and the values for the remain-
ing two were 2.1 and 1.8. Among the
26 TBM patients with CSF cultures nega-
tive for M. tuberculosis, only 4 did not
have detectable amounts of lysozyme in
CSF. Of the remaining 22 samples, 9
exhibited values < 2, 5 showedvalues bet-
ween 2 and 2.99 and 8 had values > 3.
The mean lysozyme concentration was
found to be higher in culture-positive than
in culture-negative TBM group. In the
non-TRM grouponly two specimens
had values > 1.8 out of 5 positive for
lysozyme. Among the controls, the single
Fig. Lysozyme levels [loge, µg/ml)–1] in CSF
in the different groups
Group No. Mean±SD
Control 13 0.05±0.19
Non-TBM 16 0.56±0.99
Culture –ve TBM 26 2.05±1.59
Culture +ve TBM 11 3.07±0.78
positive result had a value of 0.7. The
mean lysozyme levels in culture-positive
and culture-negative TBM groups were
significantly higher than in the non-TBM
and control groups (P<0.01).
From this it is evident that the lyso-
zyme levels were found to be elevated in
all the bacteriologically confirmed patients
(culture-positive) of TBM, the lowest
estimate among this group being 1.8.
Among the culture-negative TBM group,
approximately half the samples showed
values of 1.8 or more. The enzyme was
not detected in most of the non-TBM
patients and in 12 out of 13 control sub-
jects. In view of these findings, it seems
possible that a lysozyme concentration
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of 1.8 or above in CSF specimens may
prove as valuable aid in the diagnosis
of TBM. By applying this criterion only
13 out of 26 patients could be confirmed
as TBM among culture negative TBM
group. However, from the observations,
if a level of 1.0 is considered as the
diagnostic criterion, 21 patients from
culture-negative TBM group would have
been classified as definite TBM cases
thereby increasing the sensitivity of the
assay. Though two patients from the
non-TBM group would be classified as
TBM the specificity of the assay is not
much altered.
The preliminary observations are en-
couraging and it may be possible to arrive
at a definite criterion (lysozyme level)
for diagnosis of TBM by assaying a suffi-
ciently large number of TBM patients
with and without bacteriological confir-
mation.
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